JPMorgan Downgrades Teva Pharma (TEVA) to Underweight

November 4, 2013 6:48 AM EST Send to a Friend
Get Alerts TEVA Hot Sheet
Price: $51.45 +1.54%

Rating Summary:
    14 Buy, 16 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 13 | New: 52
Trade TEVA Now!
Join SI Premium – FREE
JPMorgan downgraded Teva Pharma (NYSE: TEVA) from Neutral to Underweight with a price target of $38.00 (from $43.00).

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $37.12 yesterday.




You May Also Be Interested In


Related Categories

Analyst PT Change, Downgrades

Related Entities

JPMorgan

Add Your Comment